All In Biotech

Drug Trial Radar · NCT04346862

Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease

Phase IV Study to Evaluate the Effect of Improvement in Cognitive Impairment of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease

Last checked: Nov 19, 2026Latest source record: Apr 21, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 636 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

636

Planned (sponsor's estimate)

Start

Jan 26, 2016

Primary completion

Jun 30, 2020

Study completion Jun 30, 2020

Sponsor

Sponsor type
Industry
First posted
Apr 15, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 55 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy of Acetyl-L-carnitine in patient with Mild Cognitive Impairment associated with chronic cerebrovascular disease.

Conditions

  • Mild Cognitive Impairment

Interventions

  • Acetyl-L-carnitine hydrochloride 500mgDrug

    The participants will receive treatment of Acetyl-L-carnitine hydrochloride 500mg, orally, 3 times a day for 24weeks

  • PlaceboDrug

    The participants will receive treatment of placebo of Acetyl-L-carnitine hydrochloride 500mg, orally, 3 times a day for 24weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Interference score using K-CWST(Korean-Color Word Stroop Test)Time frame: 24 week
  2. Montreal Cognitive Assessment Korean(MOCA-K)Time frame: 24 week

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Catholic Kwandong University International St. Mary'S Hospital

    Incheon, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.